Response of Brain Oxygen to Therapy Correlates with Long-Term Outcome After Subarachnoid Hemorrhage
- 497 Downloads
Brain oxygen (PbtO2) monitoring can help guide care of poor-grade aneurysmal subarachnoid hemorrhage (aSAH) patients. The relationship between PbtO2-directed therapy and long-term outcome is unclear. We hypothesized that responsiveness to PbtO2-directed interventions is associated with outcome.
Seventy-six aSAH patients who underwent PbtO2 monitoring were included. Long-term outcome [Glasgow Outcome Score-Extended (GOS-E) and modified Rankin Scale (mRS)] was ascertained using the social security death database and structured telephone interviews. Univariate and multivariate regression were used to identify variables that correlated with outcome.
Data from 64 patients were analyzed (12 were lost to follow-up). There were 530 episodes of compromised PbtO2 (<20 mmHg) during a total of 7,174 h of monitor time treated with 1,052 interventions. Forty-two patients (66 %) survived to discharge. Median follow-up was 8.5 months (range 0.1–87). At most recent follow-up 35 (55 %) patients were alive, and 28 (44 %) had a favorable outcome (mRS ≤3). In multivariate ordinal regression analysis, only age and response to PbtO2-directed intervention correlated significantly with outcome. Increased age was associated with worse outcome (coeff. 0.8, 95 % CI 0.3–1.3, p = 0.003), and response to PbtO2-directed intervention was associated with improved outcome (coeff. −2.12, 95 % CI −4.0 to −0.26, p = 0.03). Patients with favorable outcomes had a 70 % mean rate of response to PbtO2-directed interventions whereas patients with poor outcomes had a 45 % response rate (p = 0.005).
Response to PbtO2-directed intervention is associated with improved long-term functional outcome in aSAH patients.
KeywordsBrain tissue oxygen pressure Brain hypoxia Cerebral perfusion pressure Outcome Subarachnoid hemorrhage
Supported by Research Grants from the Integra Foundation (PDL), Integra Neurosciences (PDL), and the Mary Elisabeth Groff Surgical and Medical Research Trust (PDL). PDL is a member of Integra’s Speaker’s Bureau and a Consultant for Integra LifeSciences.
- 4.Drake CG. Report of World Federation of Neurosurgical Societies Committee on universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;38:575–80.Google Scholar
- 17.Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(Suppl 1):S1–106.Google Scholar
- 22.Oddo M, Levine JM, Frangos S, Maloney-Wilensky E, LeRoux PD. Correlation between brain oxygen and cerebral perfusion pressure and its impact on outcome after severe traumatic brain injury. 2013. (unpublished data).Google Scholar
- 39.Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI) (BOOST 2), ClinicalTrials.gov Identifier: NCT00974259.Google Scholar